CaRe Clinic Joins hyperCORE International, Expanding Clinical Trial Capabilities in Canada

In a significant development for clinical research in Canada, CaRe Clinic has joined hyperCORE International's collaborative super network of clinical trial sites. This alliance marks a notable expansion of hyperCORE's global reach and capabilities, particularly in the Canadian market.

CaRe Clinic, a growing multi-specialty research organization based in Alberta, brings to the table two state-of-the-art research centers located in Calgary and Red Deer. These facilities serve central Alberta and have a track record of participating in hundreds of clinical trials across various medical fields, including women's health, dermatology, general medicine, vaccines, infectious diseases, and migraine treatments.

One of CaRe Clinic's most significant assets is its access to a vast pool of potential patients. Through a combination of investigators' patient databases and partnerships with affiliated clinics, the organization can tap into a reservoir of over 1.8 million potential participants. This extensive reach, coupled with CaRe Clinic's community-centric recruitment strategy, positions the organization to facilitate recruitment across a wide range of medical indications.

Troy Hamilton, Director of Operations at CaRe Clinic, emphasized the strategic importance of this partnership, stating, "Joining hyperCORE International was a chance to improve how we deliver clinical trials. This partnership opens doors for unprecedented collaboration and the sharing of best practices across borders, which is crucial for the advancement of clinical research." Hamilton also expressed the organization's aim to highlight Canada's robust clinical research ecosystem on the global stage and contribute to pioneering breakthroughs that will benefit patients worldwide.

The addition of CaRe Clinic to hyperCORE International's network is expected to have significant implications for the clinical research landscape. hyperCORE, already an industry leader in Phase I-IV clinical trial services, now expands its presence in Canada with multiple locations and a multi-therapeutic offering. The super network boasts more than 120 active research sites across two continents and five countries, with its alliance partners collectively completing over 7,000 studies involving more than 150,000 randomized patients.

Carlos Orantes, President of hyperCORE and CEO at alliance partner Alcanza Clinical Research, welcomed CaRe Clinic, stating, "This immediately increases hyperCORE's footprint at multiple locations in Canada with a multi-therapeutic offering and adds a solid partner to the team. We are excited to start working closely with the CaRe Clinic team!"

The collaboration is set to enhance the efficiency and effectiveness of clinical trials. hyperCORE International's model allows each alliance partner to operate independently while integrating common functions to streamline business and clinical operations. This approach facilitates the harmonization and sharing of best practices across the network.

For patients and the broader medical community, this partnership could mean increased access to cutting-edge clinical trials and potentially faster development of new treatments. The extensive patient database and recruitment capabilities of CaRe Clinic, combined with hyperCORE's global reach and expertise, may accelerate the pace of medical research and innovation.

As the clinical research landscape continues to evolve, collaborations like this one between CaRe Clinic and hyperCORE International are likely to play a crucial role in advancing medical science and improving patient outcomes. The partnership not only strengthens Canada's position in the global clinical research arena but also contributes to the broader goal of enhancing healthcare through innovative research and development.